http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113577069-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bae7cf399c53b51787e575edaf8b820 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188 |
| filingDate | 2021-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f31ee067e975bffde0fa7587030599d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c974266f88796d4755cc3e24516f17af |
| publicationDate | 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113577069-A |
| titleOfInvention | A kind of adjuvant drug composition in radiotherapy and chemotherapy for newly diagnosed glioblastoma |
| abstract | The invention relates to an adjuvant drug composition used in radiotherapy and chemotherapy for newly diagnosed glioblastoma, which is used for the postoperative concurrent radiochemotherapy treatment of newly diagnosed glioblastoma. The pharmaceutical composition comprises: a combination of two separate reagents, temozolomide and apatinib mesylate, through the use of the auxiliary pharmaceutical composition, the therapeutic effect of newly diagnosed glioblastoma is improved, and the treatment of glioma is provided. new strategies and ideas. |
| priorityDate | 2021-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.